prof. Wouter Huvenne

Conference Paper
C3
open access

Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Gabriële Holtappels (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Amber Meskens (UGent) , Sara Neyt (UGent) , et al.

(2025) 38th Annual Congress of the European Association of Nuclear Medicine - Abstracts. In EANM Innovation 1. p.s238-s239

Add to list

Non-tumour-specific PSMA-targeted radionuclide therapy enhances immune checkpoint inhibition in a syngeneic oral cancer model

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Amber Meskens (UGent) , Christian Vanhove (UGent) and Jens Debacker (UGent)

(2025) Book of Abstracts - 49th European Radiation Research Society Meeting.

Add to list

Conference Paper
C3
open access

Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Sylvie Rottey (UGent) , Michael Saerens (UGent) , et al.

(2025) 11th European Congress on Head & Neck Oncology, Abstracts.

Add to list

Contact immunofluorescence : a novel methodology for intraoperative ex vivo margin assessment using fluorescent EGFR-targeting nanobodies

Jens Debacker (UGent) , Nayra Cristina Herreira do Valle (UGent) , David Creytens (UGent) , Menekse GOKER (UGent) , Simone Janssen (UGent) , Mathieu Struys (UGent) , Michaël Henrotte (UGent) , Wouter Huvenne (UGent) , Koen Van de Vijver (UGent) , Glenn Vergauwen (UGent) , et al.

(2024) EUROPEAN JOURNAL OF SURGICAL ONCOLOGY. In European Journal of Surgical Oncology 50(Supplement 2). p.109-110

Add to list

Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Sara Neyt (UGent) , Christian Vanhove (UGent) and Jens Debacker (UGent)

(2024) EANM'24 : 37th Annual Congress of the European Association of Nuclear Medicine.

Add to list

Journal Article
A1
open access

Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma

Bliede Van den Broeck (UGent) , Jens Debacker (UGent) , Wouter Bauters (UGent) , David Creytens (UGent) , Liesbeth Ferdinande (UGent) , Wouter Huvenne (UGent) , Bruno Lapauw (UGent) , Vanessa Schelfhout (UGent) , Nick Van Laeken (UGent) and Charlotte Verroken (UGent)

(2024) EJNMMI RESEARCH. 14(1).

Add to list

Conference Paper
C3
open access

Weekly vs 3-weekly cisplatin : a retrospective cohort study

Michael Saerens (UGent) , Alexander Van den Broeck, Geertrui Van de Weghe, Wouter Huvenne (UGent) , Peter Tomassen (UGent) , Wouter Bauters (UGent) , Tijl Vermassen (UGent) , Sarah Deschuymer (UGent) , Sylvie Rottey (UGent) and Fréderic Duprez (UGent)

(2024) RADIOTHERAPY AND ONCOLOGY. In Radiotherapy and Oncology 192(Supplement 1). p.S280-S283

Add to list

Journal Article
A1
open access

Retrospective analysis of cartilage-sparing resection of melanoma of the external ear

Jolien Govaert, Lieve Brochez (UGent) , Nicolas Dhooghe (UGent) , Celine Jacobs (UGent) , Hubert Vermeersch (UGent) and Wouter Huvenne (UGent)

(2024) B-ENT. 20(2). p.128-133

Add to list

Divergent fates : the ambiguous role of M2-like TAMs in oropharyngeal cancer

Michael Saerens (UGent) , Michel Struys (UGent) , Wouter Huvenne (UGent) , Sylvie Rottey (UGent) , Fleur Cordier (UGent) , S Fadei, David Creytens (UGent) , W Waelput, Tijl Vermassen (UGent) and Jens Debacker (UGent)

(2024) ANNALS OF ONCOLOGY. In Annals of Oncology 35(Supplement 2). p.S645-S645

Add to list

Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Michaël Henrotte (UGent) , David Creytens (UGent) , Hilde De Cock (UGent) , Filip De Vos (UGent) , Benedicte Descamps (UGent) , Lindsey Devisscher (UGent) , Wouter Huvenne (UGent) , Ken Kersemans (UGent) , Lieselotte Moerman (UGent) , Christian Vanhove (UGent) , et al.

(2024) OncoPoint Symposium, 10th, Abstracts.

Academic Bibliography

prof. Wouter Huvenne

Fractionated versus single-dose PSMA-targeted radioligand therapy as adjuvant therapy in a murine model for oral squamous cell carcinoma treated with immune checkpoint inhibitors

Non-tumour-specific PSMA-targeted radionuclide therapy enhances immune checkpoint inhibition in a syngeneic oral cancer model

Prostate-specific membrane antigen-targeted radionuclide therapy as adjunct to Immune checkpoint Inhibition in an immunocompetent murine model for oral squamous cell carcinoma

Contact immunofluorescence : a novel methodology for intraoperative ex vivo margin assessment using fluorescent EGFR-targeting nanobodies

Prostate-specific membrane antigen-targeted radionuclide therapy as a novel therapeutic approach in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Potential application of [18F]AlF-PSMA-11 PET/CT in radioiodine refractory thyroid carcinoma

Weekly vs 3-weekly cisplatin : a retrospective cohort study

Retrospective analysis of cartilage-sparing resection of melanoma of the external ear

Divergent fates : the ambiguous role of M2-like TAMs in oropharyngeal cancer

Prostate-specific membrane antigen as a potential theranostic target in a syngeneic immunocompetent murine model for oral squamous cell carcinoma

Contents

Support

Contact